CALIFORNIA LIFE SCIENCES POLITICAL ACTION COMMITTEE | PubSys CalAccessCommittee header
CALIFORNIA LIFE SCIENCES POLITICAL ACTION COMMITTEE
Active cycles
2005-20062007-20082009-20102011-20122013-20142015-20162017-20182019-20202021-20222023-20242025-2026
Panel 2 • Finance overview
Committee finance snapshot
Scope: 2025-2026 cycle
- Raised
- $268,058Dated receipts + reported unitemized intervals
- Spent
- $201,232
- Net activity
- $66,826
Receipt coverage evidence (32 components)
- Filing 2996540, amendment 0, F497P2: Receipt date 2025-01-10; $2,000.00; s497_not_received
- Filing 3007254, amendment 0, F497P2: Receipt date 2025-01-29; $2,000.00; s497_not_received
- Filing 3026089, amendment 0, F497P2: Receipt date 2025-03-03; $1,000.00; s497_not_received
- Filing 3073539, amendment 0, F497P2: Receipt date 2025-08-06; $25,000.00; s497_not_received
- Filing 3128700, amendment 0, F497P2: Receipt date 2026-03-25; $1,500.00; s497_not_received
- Filing 3128700, amendment 0, F497P2: Receipt date 2026-03-25; $5,900.00; s497_not_received
- Filing 3128700, amendment 0, F497P2: Receipt date 2026-03-25; $2,000.00; s497_not_received
- Filing 3128700, amendment 0, F497P2: Receipt date 2026-03-25; $25,000.00; s497_not_received
- Filing 3128700, amendment 0, F497P2: Receipt date 2026-03-25; $1,500.00; s497_not_received
- Filing 3128700, amendment 0, F497P2: Receipt date 2026-03-25; $2,000.00; s497_not_received
- Filing 3128700, amendment 0, F497P2: Receipt date 2026-03-25; $2,000.00; s497_not_received
- Filing 3128700, amendment 0, F497P2: Receipt date 2026-03-25; $5,900.00; s497_not_received
- Filing 3137879, amendment 0, F497P2: Receipt date 2026-04-23; $5,900.00; s497_not_received
Panel 3 • Money structure snapshot
Money structure snapshot
$5,000+ is the largest bucket at 48.8% of dated attributable receipts.
Dominant category: Operations at 93.1% of spending.
Funding distribution
$5,000+
Count: 15
Share: 48.8%
Amount: $121,600
$1,000 - $4,999
Count: 23
Share: 16.2%
Amount: $40,423
$500 - $999
Panel 5 • Financial evidence
Filings workspace
Filing history and transaction-level evidence moved to a dedicated page.
Open filings page Filing 3137879, amendment 0, F497P2: Receipt date 2026-04-23; $5,900.00; s497_not_receivedFiling 3137879, amendment 0, F497P2: Receipt date 2026-04-23; $1,500.00; s497_not_receivedFiling 3137879, amendment 0, F497P2: Receipt date 2026-04-23; $2,000.00; s497_not_receivedFiling 3137879, amendment 0, F497P2: Receipt date 2026-04-23; $1,500.00; s497_not_receivedFiling 3145762, amendment 0, F497P2: Receipt date 2026-04-30; $1,500.00; s497_not_receivedFiling 3155043, amendment 0, F497P2: Receipt date 2026-05-20; $1,500.00; s497_not_receivedFiling 3063017, amendment 0, F460: 2025-01-01 – 2025-06-30; amount unknown; accepted · whole interval in windowFiling 3085745, amendment 0, F460: 2025-07-01 – 2025-09-30; amount unknown; accepted · whole interval in windowFiling 3106787, amendment 0, F460: 2025-10-01 – 2025-12-31; amount unknown; accepted · whole interval in windowFiling 3135949, amendment 0, F460: 2026-01-01 – 2026-04-18; amount unknown; accepted · whole interval in windowFiling 3154166, amendment 0, F460: 2026-04-19 – 2026-05-16; amount unknown; accepted · whole interval in windowFiling 3173843, amendment 0, F460: 2026-05-17 – 2026-06-30; amount unknown; accepted · whole interval in windowFiling 3198375, amendment 0, F460: 2026-07-01 – 2026-09-19; amount unknown; accepted · whole interval in windowFiling 3063017, amendment 0, A: 2025-01-01 – 2025-06-30; $2,235.00; accepted · whole interval in windowFiling 3085745, amendment 0, A: 2025-07-01 – 2025-09-30; $3,745.00; accepted · whole interval in windowFiling 3106787, amendment 0, A: 2025-10-01 – 2025-12-31; $2,525.00; accepted · whole interval in windowFiling 3135949, amendment 0, A: 2026-01-01 – 2026-04-18; $4,920.00; accepted · whole interval in windowFiling 3173843, amendment 0, A: 2026-05-17 – 2026-06-30; $2,245.00; accepted · whole interval in windowFiling 3198375, amendment 0, A: 2026-07-01 – 2026-09-19; $3,380.00; accepted · whole interval in windowBroad-base funded, Non-media-led spender, Active in 2025-2026 cycle.
Money over time
Dated receipts only; unitemized reporting intervals are not allocated to dates.
ContributionsExpenditures
Jan 2025Aug 2025Feb 2026Sep 2026
Count: 12
Share: 3.5%
Amount: $8,620
$100 - $499
Count: 320
Share: 31%
Amount: $77,100
$1 - $99
Count: 19
Share: 0.5%
Amount: $1,265
| Contribution bucket | Count | Amount | Share of dated receipts |
|---|
| $5,000+ | 15 | $121,600 | 48.8% |
| $1,000 - $4,999 | 23 | $40,423 | 16.2% |
| $500 - $999 | 12 | $8,620 | 3.5% |
| $100 - $499 | 320 | $77,100 | 31% |
| $1 - $99 | 19 | $1,265 | 0.5% |
Spending categories
Operations
Amount: $187,400
Share: 93.1%
Consulting
Amount: $13,832
Share: 6.9%
| Category | Amount | Share of spent |
|---|
| Operations | $187,400 | 93.1% |
| Consulting | $13,832 | 6.9% |
Panel 4 • Top donors
Top donors
| Donor | Total | Share* | Count | Last |
|---|
| AMGEN, INC. | $19,600 | 7.9% | 2 | May 22, 2026 |
| GENENTECH, INC. | $19,600 | 7.9% | 2 | May 19, 2026 |
| GILEAD SCIENCES, INC. | $19,600 | 7.9% | 2 | Jun 22, 2026 |
| MASIMO CORPORATION | $18,900 | 7.6% | 2 | May 19, 2026 |
| NEUROCRINE BIOSCIENCES, INC. | $14,000 | 5.6% | 3 | Apr 13, 2026 |
| ACADIA PHARMACEUTICALS | $9,800 | 3.9% | 1 | Sep 15, 2025 |
| EDWARDS LIFESCIENCES CORPORATION | $8,100 | 3.3% | 1 | Feb 18, 2026 |
| ABBVIE PAC | $6,000 | 2.4% | 1 | Nov 20, 2025 |
| VERACYTE, INC. | $5,668 | 2.3% | 3 | Sep 9, 2026 |
| ABBOTT LABORATORIES EMPLOYEE PAC | $5,000 | 2% | 1 | Jul 18, 2025 |
| JOHNSON AND JOHNSON CORPORATE POLITICAL FUND | $5,000 | 2% | 1 | Dec 19, 2025 |
| GUARDANT HEALTH, INC. | $4,950 | 2% | 1 | Apr 13, 2026 |
| PTC THERAPEUTICS, INC. | $4,950 | 2% | 2 | Mar 17, 2026 |
| LATHAM & WATKINS | $2,750 | 1.1% | 2 | Apr 13, 2026 |
| ALPHATEC SPINE, INC. | $2,650 | 1.1% | 2 | Nov 13, 2025 |
| HEALTHPEAK PROPERTIES, INC. | $2,375 | 1% | 2 | May 19, 2026 |
| SANTA CRUZ NUTRITIONALS | $2,190 | 0.9% | 2 | Feb 18, 2026 |
| BILLIONTOONE, INC. | $1,775 | 0.7% | 2 | Apr 13, 2026 |
| IRHYTHM TECHNOLOGIES, INC. | $1,750 | 0.7% | 1 | Oct 14, 2025 |
| NEKTAR THERAPEUTICS | $1,575 | 0.6% | 2 | Apr 13, 2026 |
| REVOLUTION MEDICINES, INC. | $1,500 | 0.6% | 2 | Mar 17, 2026 |
| SILA NANOTECHNOLOGIES, INC. | $1,500 | 0.6% | 2 | Jul 22, 2025 |
| GRAIL, LLC(MEGAN HALL) | $1,440 | 0.6% | 1 | May 19, 2026 |
| AMPAC FINE CHEMICALS | $1,375 | 0.6% | 1 | Jan 20, 2026 |
| MILLIPORESIGMA | $1,375 | 0.6% | 1 | Mar 17, 2026 |
* Share is percent of committee total raised in the selected scope. Page rows are a subset and typically do not sum to 100%.